Joe Glajch on Biosimilars Part 3: Strategies for Demonstrating Similarity

(5:31)

Joe Glajch on Biosimilars Part 1: Analytical Methods

(7:46)

Joe Glajch on Biosimilars Part 2: FDA Expectations

(4:21)

The Glajch Family | Church Family Story of God at Work

(7:16)

Chatham Celebration of Youth 2019 - Jenna Glajch

(58)

Biosimilars Can Help Alleviate COVID-19-Driven Budget Pressure

(2:23)

Bioanalytical Support of Biosimilars Expect the Unexpected

(1:13)

MY MAINTENANCE SET AFTER REJUVENATING SET | GLASS SKIN

(10:9)

Joe Cagle performs live

(4:43)

Competitive ELISA

(4:51)

Aspects of Comparability for Biologics

(19:14)

Come Behold the Wondrous Mystery | Virtual Choir

(3:34)

Biosimilar Characterization

(7:57)

Behind the Scenes : The Magic of Biosimilars

(4:5)

Amgen's Virtual Health Equity 2020 Summit

(3:23:1econd)

2019 Inaugural Amgen Asia Scholars Symposium Highlights

(3:1econd)

Joe Gagnier 2026 Fall highlights

(1:4)

Biologics or Biosimilars and COVID 19 for Hidradenitis Suppurativa (HS)

(3:23)

Protein analysis for upscaling of batches | Biologics development | HCP ELISA assays

(1:1econd)

Pursell Farms: a casual round!

(9:37)

Biosimilars: What's on the Horizon with with Dr Jim Roach and Valerie Bowling

(5:20)

Dr. Hurvitz on the Impact of Biosimilars

(1:38)